Latest Coronary stent Stories
NATICK, Mass., May 1, 2014 /PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIER(TM) Everolimus-Eluting
- First-of-its-Kind Dissolving Medical Device Being Evaluated in People with Blocked Heart Vessels ABBOTT PARK, Ill., April 10, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced
DALLAS, April 8, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Market Research Report on Global and China Coronary Stent Industry" and "2014 Deep Research Report on Global
DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/znsx2b/global_and ) has announced the addition of the "Global and
These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease NATICK, Mass., April 1, 2014 /PRNewswire/
Allows quick and easy assessment of FFR values with Ultra-Thin Navvus(TM) MicroCatheter that can be used over standard 0.014 inch guidewires EDEN PRAIRIE, Minn., March 29, 2014 /PRNewswire/
Supera Stent Addresses Growing Need in the U.S.
Post-Market Registry to Evaluate Long-Term Safety and Performance in Routine Practice HONG KONG, March 28, 2014 /PRNewswire/ -- OrbusNeich today announced the completion of enrollment
Includes Late Breaking Clinical Trial Assessing Use of the Boston Scientific CRT-D Therapyin Patients with Mild Heart Failure NATICK, Mass., March 27, 2014 /PRNewswire/ -- At the 63(rd) Annual
- Growing in low tufty patches.
More Images (1 images) »